Beit Jala Pharmaceutical Co (XPAE:BJP) Other Financing: JOD0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Beit Jala Pharmaceutical Co Other Financing?

Beit Jala Pharmaceutical Co XPAE:BJP Other Financing is JOD0.00 Mil as of . 20. The stock has 1 warning sign investors should review.

Beit Jala Pharmaceutical Co's Other Financing for the six months ended in . 20 was JOD0.00 Mil.

Beit Jala Pharmaceutical Co's Other Financing for the trailing twelve months (TTM) ended in . 20 was JOD0.00 Mil.

Beit Jala Pharmaceutical Co Other Financing Historical Data

* Premium members only.

The historical data trend for Beit Jala Pharmaceutical Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beit Jala Pharmaceutical Co Other Financing Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
Other Financing

Beit Jala Pharmaceutical Co Semi-Annual Data
Other Financing

Beit Jala Pharmaceutical Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in . 20 was JOD0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of JOD0.00 Mil mean?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a Other Financing of JOD0.00 Mil as of . 20. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Beit Jala Pharmaceutical Co and its competitors.
Is Beit Jala Pharmaceutical Co's Other Financing too high?
Beit Jala Pharmaceutical Co's current Other Financing is JOD0.00 Mil.
How does Beit Jala Pharmaceutical Co's Other Financing compare to ?
Beit Jala Pharmaceutical Co's Other Financing of JOD0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Beit Jala Pharmaceutical Co and its competitors. Beit Jala Pharmaceutical Co's current Other Financing is JOD0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beit Jala Pharmaceutical Co stock overvalued right now?
Beit Jala Pharmaceutical Co (XPAE:BJP) has a current Other Financing of JOD0.00 Mil. The current Other Financing is JOD0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Beit Jala Pharmaceutical Co (XPAE:BJP), the current Other Financing is JOD0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beit Jala Pharmaceutical Co Business Description

Comparable Companies
Address 81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.